ClinVar Miner

Submissions for variant NM_058216.3(RAD51C):c.186A>G (p.Gln62=) (rs28363303)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 13
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000131123 SCV000186054 benign Hereditary cancer-predisposing syndrome 2014-11-25 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance
Color RCV000131123 SCV000686330 benign Hereditary cancer-predisposing syndrome 2015-08-17 criteria provided, single submitter clinical testing
Counsyl RCV000203729 SCV000489811 benign Fanconi anemia, complementation group O 2016-05-25 criteria provided, single submitter clinical testing
Counsyl RCV000412091 SCV000489812 benign Breast-ovarian cancer, familial 3 2016-05-25 criteria provided, single submitter clinical testing
GeneDx RCV000212933 SCV000171269 benign not specified 2014-03-14 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Illumina Clinical Services Laboratory,Illumina RCV000375230 SCV000404319 likely benign Fanconi anemia 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000281149 SCV000404320 likely benign Breast and Ovarian Cancer Susceptibility 2016-06-14 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000586849 SCV000699797 benign not provided 2016-07-01 criteria provided, single submitter clinical testing Variant summary: The c.186A>G (p.GLn62=) in RAD51C gene is a synonymous change that involves a non-conserved nucleotide. 5/5 programs in Alamut predict that this variant does not affect normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in the control population dataset of ExAC at frequency of 0.001(123/121184 chrs tested), predominantly in individuals of African origin (0.01; 117/10292 control chrs). This frequency greatly exceeds the maximal expected frequency of a pathogenic allele (0.00006) in this gene. The variant of interest has been reported in several affected individuals in co-occurrence with known pathogenic variant in BRCA2 gene in at least 1HBOC family. In addition, the variant has been classified as Benign by reputable databases/clinical laboratory. Taking together, the variant was classified as Benign.
Invitae RCV000203729 SCV000261112 benign Fanconi anemia, complementation group O 2018-01-08 criteria provided, single submitter clinical testing
PreventionGenetics RCV000212933 SCV000315330 benign not specified criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000212933 SCV000602137 likely benign not specified 2017-02-02 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000586849 SCV000888594 benign not provided 2018-07-11 criteria provided, single submitter clinical testing
True Health Diagnostics RCV000131123 SCV000788199 likely benign Hereditary cancer-predisposing syndrome 2017-09-13 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.